↓ Skip to main content

Drug repurposing candidates to treat core symptoms in autism spectrum disorder

Overview of attention for article published in Frontiers in Pharmacology, September 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#20 of 20,601)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
35 news outlets
blogs
8 blogs
twitter
217 X users
facebook
1 Facebook page

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Drug repurposing candidates to treat core symptoms in autism spectrum disorder
Published in
Frontiers in Pharmacology, September 2022
DOI 10.3389/fphar.2022.995439
Pubmed ID
Authors

Elise Koch, Ditte Demontis

X Demographics

X Demographics

The data shown below were collected from the profiles of 217 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 24%
Student > Bachelor 2 12%
Other 1 6%
Lecturer 1 6%
Student > Master 1 6%
Other 1 6%
Unknown 7 41%
Readers by discipline Count As %
Neuroscience 3 18%
Agricultural and Biological Sciences 2 12%
Psychology 2 12%
Medicine and Dentistry 2 12%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Other 1 6%
Unknown 6 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 449. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 July 2024.
All research outputs
#66,176
of 26,557,909 outputs
Outputs from Frontiers in Pharmacology
#20
of 20,601 outputs
Outputs of similar age
#1,990
of 440,101 outputs
Outputs of similar age from Frontiers in Pharmacology
#2
of 1,511 outputs
Altmetric has tracked 26,557,909 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,601 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,101 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 1,511 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.